Inmune Bio (INMB) Total Liabilities (2017 - 2026)
Inmune Bio's Total Liabilities came in at $6.48 million for Q2 2026, down 26.5% from $8.82 million a year earlier but up 4.7% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Total Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Inmune Bio's Total Liabilities was $8.83 million, up 18.2% from FY2024.
- Total Liabilities carries a five-year compound annual growth rate of 35.9% (FY2020 to FY2025).
- Going back by year, Total Liabilities was $7.47 million in FY2024 (-62.0%), $19.66 million in FY2023 (-9.4%), $21.69 million in FY2022 (+10.0%) and $19.72 million in FY2021 (+936.8%).
- The five-year range for quarterly Total Liabilities is $6.19 million (Q1 2026) to $21.69 million (Q4 2022).
- Year-over-year, Total Liabilities increased in 1 of the last eight quarters, with an average decline of 33.0%.
- The fastest year-over-year change in Total Liabilities over five years came in Q4 2021 (growth of 936.8%), and the weakest in Q4 2024 (a decline of 62.0%).
- Business Quant data shows INMB's Total Liabilities at $6.19 million (Q1 2026), $8.83 million (Q4 2025) and $7.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Inmune Bio | 55.31 Mn | -36.95 Mn | - | 6.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.48 Mn |
| Mar 31, 2026 | 6.19 Mn |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | 7.98 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 8.13 Mn |
| Dec 31, 2024 | 7.47 Mn |
| Sep 30, 2024 | 14.11 Mn |
| Jun 30, 2024 | 16.17 Mn |
| Mar 31, 2024 | 18.61 Mn |
| Dec 31, 2023 | 19.66 Mn |
| Sep 30, 2023 | 18.77 Mn |
| Jun 30, 2023 | 19.07 Mn |
| Mar 31, 2023 | 18.68 Mn |
| Dec 31, 2022 | 21.69 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 17.88 Mn |
| Mar 31, 2022 | 18.71 Mn |
| Dec 31, 2021 | 19.72 Mn |
| Sep 30, 2021 | 19.42 Mn |
API Access
Inmune Bio Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();